| Lastest Insider Transactions Of Prometheus Biosciences, Inc. ( RXDX ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | 2023-06-02 | Option Exercise | 122,531 | 2.90 | 355,336 | 2023-06-02 19:13:46 |
| RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | 2023-06-02 | Option Exercise | 78,162 | 3.10 | 242,302 | 2023-06-02 19:03:59 |
| RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | 2023-04-05 | Sell | 10,000 | 108.42 | 1,084,200 | 2023-04-07 21:02:53 |
| RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | 2023-04-05 | Option Exercise | 10,000 | 3.70 | 37,000 | 2023-04-07 21:02:53 |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | 2023-03-15 | Sell | 25,000 | 116.14 | 2,903,500 | 2023-03-17 21:02:53 |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | 2023-03-15 | Option Exercise | 25,000 | 2.90 | 72,500 | 2023-03-17 21:02:53 |
| RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | 2023-03-06 | Sell | 10,000 | 122.13 | 1,221,300 | 2023-03-08 21:33:41 |
| RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | 2023-03-06 | Option Exercise | 10,000 | 3.70 | 37,000 | 2023-03-08 21:33:41 |
| RXDX | Prometheus Biosciences, Inc. | Cedars Sinai Intellectual Property Co | 10% Owner | 2023-03-08 | Sell | 865,000 | 114.59 | 99,120,352 | 2023-03-08 21:30:17 |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | 2023-03-01 | Sell | 11,320 | 125.14 | 1,416,563 | 2023-03-03 21:30:57 |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | 2023-03-01 | Option Exercise | 11,320 | 3.70 | 41,884 | 2023-03-03 21:30:57 |
| RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | 2023-02-15 | Sell | 5,000 | 119.38 | 596,900 | 2023-02-17 21:34:06 |
| RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | 2023-02-15 | Option Exercise | 5,000 | 3.70 | 18,500 | 2023-02-17 21:34:06 |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | 2023-02-15 | Sell | 63,680 | 120.82 | 7,693,618 | 2023-02-17 21:31:13 |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | 2023-02-15 | Option Exercise | 63,680 | 3.39 | 215,616 | 2023-02-17 21:31:13 |
| RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | 2023-01-17 | Sell | 5,000 | 119.00 | 595,000 | 2023-01-19 20:42:26 |
| RXDX | Prometheus Biosciences, Inc. | Marshall Keith W | Chief Financial Officer | 2023-01-17 | Option Exercise | 5,000 | 3.70 | 18,500 | 2023-01-19 20:42:26 |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | 2023-01-17 | Sell | 25,000 | 118.99 | 2,974,750 | 2023-01-19 20:39:19 |
| RXDX | Prometheus Biosciences, Inc. | McKenna Mark C. | Chairman, President & CEO | 2023-01-17 | Option Exercise | 25,000 | 2.90 | 72,500 | 2023-01-19 20:39:19 |
